US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nexalin Technology, Inc.

6.19

-0.6100-8.97%

Post-market: 6.04-0.1476-2.38%19:30 EDT

Volume:27.87K

Turnover:177.22K

Market Cap:4.55M

PE:-0.45

High:6.80

Open:6.77

Low:5.94

Close:6.80

52wk High:60.00

52wk Low:5.94

Shares:734.50K

Float Shares:671.71K

Volume Ratio:1.51

T/O Rate:4.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-13.8684

EPS(LYR):-15.0475

ROE:-240.25%

ROA:-119.22%

PB:2.99

PE(LYR):-0.41

Loading ...

Overview Company News Filings

Nexalin says open-label pilot trial data show 77.8% anxiety response with DIFS brain-stimulation device

Nexalin Study Shows Strong Anxiety and Depression Response in Brazil Trial

MT Newswires Live

Nexalin Technology completes neurostimulation protocol trial

Nexalin reports 77.8% anxiety response rate in Brazil trial of DIFS neurostimulation device

Nexalin Technology - No Serious Adverse Events or Seizures Reported in Nexalin Trial

THOMSON REUTERS

Nexalin Technology - Reports 77.8% Anxiety Response Rate at End of Treatment

THOMSON REUTERS

Nexalin Technology - Overall Quality of Life Improves Significantly at End of Treatment

THOMSON REUTERS

Nexalin Technology - Completes 8-Week Clinical Trial of 15 Ma, 77.5 Hz Neurostimulation in Anxiety

THOMSON REUTERS

Nexalin Technology Wins US Patent Protecting Neurostimulation Method Through 2042

MT Newswires Live

Nexalin wins US patent for dynamic frequency brain stimulation targeting anxiety, depression, insomnia

Maxim Group Reaffirms Their Buy Rating on Nexalin Technology, Inc. (NXL)

Nexalin closes acquisition of PONM digital health platform for USD 1.3 million

Nexalin Acquires AI-Integrated Digital Health Platform Behind Halo™ Clarity and Nexalin Neurocare™ Ahead of Planned FDA Pivotal Trial

THOMSON REUTERS

Nexalin Q1 FY26 net loss widens 5% to $2.1 million; revenue drops 64% to $14,950

Nexalin Technology Inc expected to post a loss of 10 cents a share - Earnings Preview

Nexalin study shows insomnia improvement with 15 mA, 77.5 Hz brain stimulation

Morgan Stanley Sticks to Their Buy Rating for Nuix Ltd. (NXL)

Nuix Ltd. (NXL) Gets a Buy from RBC Capital

BRIEF-Nexalin Technology Advances Clinical Trial Of HALO Clarity Toward Q2 2026 Enrollment

Nexalin Technology enters agreements to advance HALO Clarity trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/NXL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NXL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXL\",,,,,undefined,":{"symbol":"NXL","market":"US","secType":"STK","nameCN":"Nexalin Technology, Inc.","latestPrice":6.19,"timestamp":1788379200000,"preClose":6.8,"halted":0,"volume":27865,"hourTrading":{"tag":"盘后","latestPrice":6.0424,"preClose":6.19,"latestTime":"19:30 EDT","volume":1842,"amount":11529.1012,"timestamp":1788391805051,"change":-0.1476,"changeRate":-0.023845,"amplitude":0.041616},"delay":0,"changeRate":-0.0897058823529411,"floatShares":671706,"shares":734500,"eps":-13.86837,"marketStatus":"Closed","change":-0.61,"latestTime":"09-02 16:00:00 EDT","open":6.77,"high":6.8,"low":5.9377,"amount":177224.593329,"amplitude":0.126809,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-13.86837,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":5,"adr":0,"listingDate":1663300800000,"exchange":"NASDAQ","adjPreClose":6.8,"postHourTrading":{"tag":"盘后","latestPrice":6.0424,"preClose":6.19,"latestTime":"19:30 EDT","volume":1842,"amount":11529.1012,"timestamp":1788391805051,"change":-0.1476,"changeRate":-0.023845,"amplitude":0.041616},"volumeRatio":1.51097},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXL\",,,,,undefined,":{"symbol":"NXL","floatShares":671706,"roa":"-119.22%","roe":"-240.25%","lyrEps":-15.04746,"volumeRatio":1.51097,"shares":734500,"dividePrice":0,"high":6.8,"amplitude":0.126809,"preClose":6.8,"low":5.9377,"week52Low":5.9377,"pbRate":"2.99","psRate":"20.94","week52High":60,"institutionHeld":0,"latestPrice":6.19,"eps":-13.86837,"divideRate":0,"volume":27865,"delay":0,"ttmEps":-13.86837,"open":6.77,"prevYearClose":16.74,"prevWeekClose":7.5,"prevMonthClose":7.23,"prevQuarterClose":9.9,"fiveDayClose":8.85,"twentyDayClose":10.206,"sixtyDayClose":15.045},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NXL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-31","symbol":"NXL","defaultRemindTime":1788183000000,"type":"split","dateTimestamp":1788148800000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2026-08-12","symbol":"NXL","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2026-05-08","symbol":"NXL","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"","actualEps":-0.11},{"market":"US","date":"2026-03-25","symbol":"NXL","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"","actualEps":-0.13},{"market":"US","date":"2025-11-14","symbol":"NXL","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NXL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NXL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1742875200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NXL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NXL","date":"2026-09-01","current":-0.445618,"percent":0.961499,"low":-11.123806,"twenty":-3.730047,"median":-2.207132,"eighty":-1.011815,"high":-0.46259,"avg":-2.789227,"sd":2.225179,"marketCap":5310760},"quantilePoints":[{"date":"2022-09-16","current":-5.073734,"twenty":-6.382342,"median":-6.382342,"eighty":-5.597177,"marketCap":16379912},{"date":"2022-09-23","current":-2.773641,"twenty":-5.858899,"median":-3.709464,"eighty":-3.008161,"marketCap":8954352},{"date":"2022-09-30","current":-2.435392,"twenty":-4.568616,"median":-2.908941,"eighty":-2.579712,"marketCap":7862357},{"date":"2022-10-07","current":-2.503042,"twenty":-3.729758,"median":-2.593242,"eighty":-2.489512,"marketCap":8080756},{"date":"2022-10-14","current":-2.886391,"twenty":-3.427589,"median":-2.773641,"eighty":-2.503042,"marketCap":9318350},{"date":"2022-10-21","current":-3.044241,"twenty":-3.11189,"median":-2.852566,"eighty":-2.512062,"marketCap":9827947},{"date":"2022-10-28","current":-3.333782,"twenty":-3.13895,"median":-2.908715,"eighty":-2.525592,"marketCap":10762694},{"date":"2022-11-04","current":-3.630539,"twenty":-3.342712,"median":-2.948628,"eighty":-2.543632,"marketCap":11720737},{"date":"2022-11-11","current":-8.471203,"twenty":-3.677893,"median":-2.954041,"eighty":-2.579712,"marketCap":13249529},{"date":"2022-11-18","current":-8.378112,"twenty":-4.631756,"median":-3.015602,"eighty":-2.593242,"marketCap":13103929},{"date":"2022-11-25","current":-10.658821,"twenty":-7.755915,"median":-3.13444,"eighty":-2.629322,"marketCap":16671110},{"date":"2022-12-02","current":-10.938092,"twenty":-8.471203,"median":-3.31484,"eighty":-2.782661,"marketCap":17107908},{"date":"2022-12-09","current":-10.333006,"twenty":-9.802392,"median":-3.467052,"eighty":-2.818741,"marketCap":16161513},{"date":"2022-12-16","current":-3.444335,"twenty":-9.802392,"median":-3.607989,"eighty":-2.818741,"marketCap":5387171},{"date":"2022-12-23","current":-3.63517,"twenty":-9.44865,"median":-3.619264,"eighty":-2.832271,"marketCap":5685649},{"date":"2022-12-30","current":-3.486225,"twenty":-9.076288,"median":-3.596714,"eighty":-2.886391,"marketCap":5452690},{"date":"2023-01-06","current":-3.504843,"twenty":-8.852872,"median":-3.596714,"eighty":-2.90425,"marketCap":5481810},{"date":"2023-01-13","current":-4.326829,"twenty":-8.648074,"median":-3.630539,"eighty":-2.908896,"marketCap":6767451},{"date":"2023-01-20","current":-5.301949,"twenty":-8.527057,"median":-3.653322,"eighty":-2.929642,"marketCap":8292603},{"date":"2023-01-27","current":-5.205601,"twenty":-8.471203,"median":-3.704665,"eighty":-2.949666,"marketCap":8141908},{"date":"2023-02-03","current":-5.026867,"twenty":-8.415348,"median":-3.810938,"eighty":-2.953951,"marketCap":7862357},{"date":"2023-02-10","current":-5.678498,"twenty":-8.378112,"median":-3.923688,"eighty":-2.954041,"marketCap":8881552},{"date":"2023-02-17","current":-5.119958,"twenty":-8.21083,"median":-4.305419,"eighty":-2.967571,"marketCap":8007957},{"date":"2023-02-24","current":-4.087122,"twenty":-7.763997,"median":-4.305419,"eighty":-2.98074,"marketCap":6392533},{"date":"2023-03-03","current":-4.468326,"twenty":-6.909555,"median":-4.267252,"eighty":-3.009875,"marketCap":6988762},{"date":"2023-03-10","current":-4.747597,"twenty":-6.382342,"median":-4.328691,"eighty":-3.071301,"marketCap":7425560},{"date":"2023-03-17","current":-5.026867,"twenty":-6.100804,"median":-4.480661,"eighty":-3.12993,"marketCap":7862357},{"date":"2023-03-24","current":-4.794607,"twenty":-5.641262,"median":-4.519061,"eighty":-3.175481,"marketCap":7499087},{"date":"2023-03-31","current":-3.433381,"twenty":-5.576099,"median":-4.480661,"eighty":-3.247866,"marketCap":5829249},{"date":"2023-04-06","current":-3.31965,"twenty":-5.510936,"median":-4.366393,"eighty":-3.315802,"marketCap":5636155},{"date":"2023-04-14","current":-3.60505,"twenty":-5.306138,"median":-4.305419,"eighty":-3.315802,"marketCap":6120712},{"date":"2023-04-21","current":-3.347546,"twenty":-5.306138,"median":-4.128082,"eighty":-3.315802,"marketCap":5683518},{"date":"2023-04-28","current":-3.562562,"twenty":-5.306138,"median":-4.003341,"eighty":-3.322476,"marketCap":6048575},{"date":"2023-05-05","current":-3.733802,"twenty":-5.3053,"median":-3.915598,"eighty":-3.335677,"marketCap":6339308},{"date":"2023-05-12","current":-3.01616,"twenty":-5.282679,"median":-3.810938,"eighty":-3.335677,"marketCap":6192120},{"date":"2023-05-19","current":-2.818112,"twenty":-5.188472,"median":-3.732836,"eighty":-3.214916,"marketCap":5785530},{"date":"2023-05-26","current":-2.767002,"twenty":-5.119958,"median":-3.715347,"eighty":-3.089151,"marketCap":5680603},{"date":"2023-06-02","current":-3.273482,"twenty":-5.119958,"median":-3.699867,"eighty":-3.044241,"marketCap":6720396},{"date":"2023-06-09","current":-3.251121,"twenty":-5.119958,"median":-3.681736,"eighty":-3.052363,"marketCap":6674490},{"date":"2023-06-16","current":-3.263544,"twenty":-5.073734,"median":-3.647538,"eighty":-3.044241,"marketCap":6699993},{"date":"2023-06-23","current":-3.023969,"twenty":-5.073476,"median":-3.630539,"eighty":-3.042316,"marketCap":6208150},{"date":"2023-06-30","current":-3.229471,"twenty":-5.073412,"median":-3.607989,"eighty":-3.049114,"marketCap":6630042},{"date":"2023-07-07","current":-3.28271,"twenty":-5.073412,"median":-3.60505,"eighty":-3.06656,"marketCap":6739341},{"date":"2023-07-14","current":-2.838342,"twenty":-5.054794,"median":-3.60505,"eighty":-3.038466,"marketCap":5827063},{"date":"2023-07-21","current":-2.875965,"twenty":-5.026867,"median":-3.603763,"eighty":-3.000615,"marketCap":5904301},{"date":"2023-07-28","current":-2.789363,"twenty":-5.008249,"median":-3.588807,"eighty":-2.957877,"marketCap":5726509},{"date":"2023-08-04","current":-2.594508,"twenty":-4.961704,"median":-3.5728,"eighty":-2.942778,"marketCap":5326476},{"date":"2023-08-11","current":-2.284658,"twenty":-4.933777,"median":-3.560201,"eighty":-2.908805,"marketCap":4690359},{"date":"2023-08-18","current":-1.816454,"twenty":-4.933777,"median":-3.537425,"eighty":-2.875326,"marketCap":4424754},{"date":"2023-08-25","current":-1.282203,"twenty":-4.933777,"median":-3.497652,"eighty":-2.827127,"marketCap":3123356},{"date":"2023-09-01","current":-1.360051,"twenty":-4.915159,"median":-3.486225,"eighty":-2.818364,"marketCap":3312988},{"date":"2023-09-08","current":-1.283424,"twenty":-4.887232,"median":-3.444801,"eighty":-2.803631,"marketCap":3126330},{"date":"2023-09-15","current":-1.312732,"twenty":-4.887232,"median":-3.433381,"eighty":-2.788795,"marketCap":3197721},{"date":"2023-09-22","current":-1.312732,"twenty":-4.887139,"median":-3.39261,"eighty":-2.768493,"marketCap":3197721},{"date":"2023-09-29","current":-1.472702,"twenty":-4.877551,"median":-3.360231,"eighty":-2.700987,"marketCap":3587397},{"date":"2023-10-06","current":-1.190617,"twenty":-4.840687,"median":-3.343255,"eighty":-2.636674,"marketCap":2900259},{"date":"2023-10-13","current":-1.330438,"twenty":-4.831471,"median":-3.336304,"eighty":-2.575202,"marketCap":3240853},{"date":"2023-10-20","current":-1.010498,"twenty":-4.785205,"median":-3.31965,"eighty":-2.503042,"marketCap":2461502},{"date":"2023-10-27","current":-1.037974,"twenty":-4.766401,"median":-3.31484,"eighty":-2.480492,"marketCap":2528431},{"date":"2023-11-03","current":-0.924102,"twenty":-4.747597,"median":-3.278273,"eighty":-2.375098,"marketCap":2251047},{"date":"2023-11-10","current":-1.098726,"twenty":-4.736426,"median":-3.263544,"eighty":-1.867376,"marketCap":2676418},{"date":"2023-11-17","current":-0.465824,"twenty":-4.684017,"median":-3.249346,"eighty":-1.703376,"marketCap":2141729},{"date":"2023-11-24","current":-0.526479,"twenty":-4.652366,"median":-3.216344,"eighty":-1.47551,"marketCap":2420600},{"date":"2023-12-01","current":-0.630966,"twenty":-4.633097,"median":-3.194333,"eighty":-1.433259,"marketCap":2901002},{"date":"2023-12-08","current":-0.64714,"twenty":-4.607776,"median":-3.192381,"eighty":-1.383558,"marketCap":2975368},{"date":"2023-12-15","current":-0.622393,"twenty":-4.601166,"median":-3.165229,"eighty":-1.337643,"marketCap":2861589},{"date":"2023-12-22","current":-0.483617,"twenty":-4.588878,"median":-3.140169,"eighty":-1.312732,"marketCap":2223532},{"date":"2023-12-29","current":-0.650213,"twenty":-4.584689,"median":-3.123348,"eighty":-1.283424,"marketCap":2989497},{"date":"2024-01-05","current":-0.630804,"twenty":-4.5602,"median":-3.103112,"eighty":-1.276097,"marketCap":2900259},{"date":"2024-01-12","current":-0.750495,"twenty":-4.528986,"median":-3.052363,"eighty":-1.223467,"marketCap":3450564},{"date":"2024-01-19","current":-0.727851,"twenty":-4.517385,"median":-3.034616,"eighty":-1.19715,"marketCap":3346452},{"date":"2024-01-26","current":-0.528905,"twenty":-4.506122,"median":-3.016515,"eighty":-1.180419,"marketCap":2431755},{"date":"2024-02-02","current":-0.627407,"twenty":-4.483128,"median":-2.986964,"eighty":-1.132613,"marketCap":2884642},{"date":"2024-02-09","current":-0.490248,"twenty":-4.442634,"median":-2.958836,"eighty":-1.026617,"marketCap":2254021},{"date":"2024-02-16","current":-0.514672,"twenty":-4.373933,"median":-2.953815,"eighty":-0.975085,"marketCap":2366314},{"date":"2024-02-23","current":-0.501408,"twenty":-4.328319,"median":-2.942336,"eighty":-0.95921,"marketCap":2305334},{"date":"2024-03-01","current":-0.501733,"twenty":-4.322547,"median":-2.909667,"eighty":-0.893084,"marketCap":2306828},{"date":"2024-03-08","current":-0.881508,"twenty":-4.290152,"median":-2.892646,"eighty":-0.76764,"marketCap":4052926},{"date":"2024-03-15","current":-0.873421,"twenty":-4.211677,"median":-2.875432,"eighty":-0.727851,"marketCap":4015743},{"date":"2024-03-22","current":-0.721381,"twenty":-4.136461,"median":-2.838342,"eighty":-0.725133,"marketCap":3316706},{"date":"2024-03-28","current":-1.261608,"twenty":-4.114119,"median":-2.824855,"eighty":-0.727851,"marketCap":5800518},{"date":"2024-04-05","current":-3.439365,"twenty":-4.114119,"median":-2.834438,"eighty":-0.727851,"marketCap":15988608},{"date":"2024-04-12","current":-3.935274,"twenty":-4.087122,"median":-2.8749,"eighty":-0.727851,"marketCap":18293942},{"date":"2024-04-19","current":-2.351566,"twenty":-4.003341,"median":-2.866559,"eighty":-0.748716,"marketCap":10931746},{"date":"2024-04-26","current":-2.215591,"twenty":-3.983265,"median":-2.830534,"eighty":-0.750495,"marketCap":10299638},{"date":"2024-05-03","current":-2.639513,"twenty":-3.968788,"median":-2.818741,"eighty":-0.761817,"marketCap":12270327},{"date":"2024-05-10","current":-1.855657,"twenty":-3.967268,"median":-2.818112,"eighty":-0.782844,"marketCap":8626411},{"date":"2024-05-17","current":-2.001563,"twenty":-3.952607,"median":-2.803737,"eighty":-0.792549,"marketCap":9890627},{"date":"2024-05-24","current":-1.595231,"twenty":-3.935274,"median":-2.80356,"eighty":-0.808723,"marketCap":7882755},{"date":"2024-05-31","current":-1.053454,"twenty":-3.909679,"median":-2.788653,"eighty":-0.830719,"marketCap":5205593},{"date":"2024-06-07","current":-1.083553,"twenty":-3.883526,"median":-2.768954,"eighty":-0.840101,"marketCap":5354324},{"date":"2024-06-14","current":-1.353237,"twenty":-3.84715,"median":-2.767002,"eighty":-0.866951,"marketCap":6686956},{"date":"2024-06-21","current":-2.468093,"twenty":-3.825734,"median":-2.715187,"eighty":-0.878273,"marketCap":12195961},{"date":"2024-06-28","current":-2.543339,"twenty":-3.85501,"median":-2.750143,"eighty":-0.883801,"marketCap":12567789},{"date":"2024-07-05","current":-2.763695,"twenty":-3.830253,"median":-2.748489,"eighty":-0.900328,"marketCap":13656664},{"date":"2024-07-12","current":-3.042207,"twenty":-3.814393,"median":-2.768422,"eighty":-0.923336,"marketCap":15032918},{"date":"2024-07-19","current":-2.656575,"twenty":-3.788667,"median":-2.7686,"eighty":-0.92459,"marketCap":13127336},{"date":"2024-07-26","current":-2.656575,"twenty":-3.746677,"median":-2.767002,"eighty":-0.925468,"marketCap":13127336},{"date":"2024-08-02","current":-2.335215,"twenty":-3.733029,"median":-2.724235,"eighty":-0.933966,"marketCap":11539352},{"date":"2024-08-09","current":-1.857517,"twenty":-3.730047,"median":-2.697437,"eighty":-0.951517,"marketCap":10037108},{"date":"2024-08-16","current":-1.912181,"twenty":-3.726016,"median":-2.669971,"eighty":-0.95921,"marketCap":10332484},{"date":"2024-08-23","current":-1.887789,"twenty":-3.720581,"median":-2.656575,"eighty":-0.962629,"marketCap":10200681},{"date":"2024-08-30","current":-1.804816,"twenty":-3.712993,"median":-2.640081,"eighty":-0.9702,"marketCap":9752340},{"date":"2024-09-06","current":-1.620652,"twenty":-3.707544,"median":-2.621599,"eighty":-0.974474,"marketCap":8757204},{"date":"2024-09-13","current":-1.313449,"twenty":-3.697985,"median":-2.594508,"eighty":-0.979786,"marketCap":7097231},{"date":"2024-09-20","current":-1.360078,"twenty":-3.690112,"median":-2.581967,"eighty":-0.991663,"marketCap":7349191},{"date":"2024-09-27","current":-1.383196,"twenty":-3.685938,"median":-2.548581,"eighty":-0.995169,"marketCap":7474112},{"date":"2024-10-04","current":-1.288959,"twenty":-3.672451,"median":-2.526811,"eighty":-1.004353,"marketCap":6964899},{"date":"2024-10-11","current":-1.530136,"twenty":-3.661324,"median":-2.506607,"eighty":-1.011474,"marketCap":8268104},{"date":"2024-10-18","current":-2.468594,"twenty":-3.652165,"median":-2.503042,"eighty":-1.016112,"marketCap":13339068},{"date":"2024-10-25","current":-4.486572,"twenty":-3.661324,"median":-2.525592,"eighty":-1.021413,"marketCap":24243226},{"date":"2024-11-01","current":-6.191077,"twenty":-3.697985,"median":-2.535685,"eighty":-1.032299,"marketCap":33453535},{"date":"2024-11-08","current":-8.798889,"twenty":-3.726664,"median":-2.549455,"eighty":-1.04107,"marketCap":48874099},{"date":"2024-11-15","current":-9.771398,"twenty":-3.799802,"median":-2.589694,"eighty":-1.056464,"marketCap":54275973},{"date":"2024-11-22","current":-8.845199,"twenty":-3.898342,"median":-2.594508,"eighty":-1.071514,"marketCap":49131331},{"date":"2024-11-29","current":-9.678778,"twenty":-3.967268,"median":-2.607519,"eighty":-1.083553,"marketCap":53761508},{"date":"2024-12-06","current":-10.095568,"twenty":-4.087122,"median":-2.640081,"eighty":-1.083553,"marketCap":56076597},{"date":"2024-12-13","current":-9.169369,"twenty":-4.212284,"median":-2.656575,"eighty":-1.090175,"marketCap":50931955},{"date":"2024-12-20","current":-6.089758,"twenty":-4.326829,"median":-2.668127,"eighty":-1.098726,"marketCap":33826021},{"date":"2024-12-27","current":-6.830717,"twenty":-4.457081,"median":-2.687275,"eighty":-1.111182,"marketCap":37941734},{"date":"2025-01-03","current":-7.085421,"twenty":-4.489142,"median":-2.700469,"eighty":-1.114296,"marketCap":39356511},{"date":"2025-01-10","current":-6.159222,"twenty":-4.533949,"median":-2.724235,"eighty":-1.116687,"marketCap":34211869},{"date":"2025-01-17","current":-7.316971,"twenty":-4.601166,"median":-2.767002,"eighty":-1.126594,"marketCap":40642671},{"date":"2025-01-24","current":-6.298152,"twenty":-4.653204,"median":-2.768777,"eighty":-1.140878,"marketCap":34983565},{"date":"2025-01-31","current":-6.761252,"twenty":-4.785205,"median":-2.781147,"eighty":-1.16021,"marketCap":37555886},{"date":"2025-02-07","current":-8.613649,"twenty":-4.885096,"median":-2.80356,"eighty":-1.162531,"marketCap":47845170},{"date":"2025-02-14","current":-7.664296,"twenty":-4.924468,"median":-2.803737,"eighty":-1.170895,"marketCap":42571912},{"date":"2025-02-21","current":-6.645477,"twenty":-4.933777,"median":-2.812788,"eighty":-1.175045,"marketCap":36912806},{"date":"2025-02-28","current":-6.274997,"twenty":-5.073412,"median":-2.818741,"eighty":-1.18848,"marketCap":34854949},{"date":"2025-03-07","current":-5.510883,"twenty":-5.113516,"median":-2.827694,"eighty":-1.190617,"marketCap":30610619},{"date":"2025-03-14","current":-3.759943,"twenty":-5.113516,"median":-2.858218,"eighty":-1.190617,"marketCap":28602574},{"date":"2025-03-21","current":-4.16217,"twenty":-5.073734,"median":-2.875432,"eighty":-1.191533,"marketCap":31662384},{"date":"2025-03-28","current":-3.340229,"twenty":-5.073412,"median":-2.892239,"eighty":-1.205576,"marketCap":25409728},{"date":"2025-04-04","current":-2.95549,"twenty":-5.073412,"median":-2.904166,"eighty":-1.220583,"marketCap":22482953},{"date":"2025-04-11","current":-3.2353,"twenty":-5.073412,"median":-2.908715,"eighty":-1.221146,"marketCap":24611517},{"date":"2025-04-17","current":-2.952867,"twenty":-5.036176,"median":-2.908941,"eighty":-1.222104,"marketCap":22462998},{"date":"2025-04-25","current":-3.200324,"twenty":-5.026867,"median":-2.926364,"eighty":-1.222365,"marketCap":24345447},{"date":"2025-05-02","current":-3.130372,"twenty":-5.006553,"median":-2.952867,"eighty":-1.223833,"marketCap":23813306},{"date":"2025-05-09","current":-2.863738,"twenty":-4.984552,"median":-2.926364,"eighty":-1.232277,"marketCap":21784974},{"date":"2025-05-16","current":-2.546651,"twenty":-4.943086,"median":-2.908941,"eighty":-1.235987,"marketCap":21784974},{"date":"2025-05-23","current":-2.426337,"twenty":-4.933777,"median":-2.901322,"eighty":-1.244124,"marketCap":20755762},{"date":"2025-05-30","current":-2.389627,"twenty":-4.933777,"median":-2.892443,"eighty":-1.246052,"marketCap":20441735},{"date":"2025-06-06","current":-2.389627,"twenty":-4.933777,"median":-2.885538,"eighty":-1.247409,"marketCap":20441735},{"date":"2025-06-13","current":-2.439829,"twenty":-4.90585,"median":-2.872857,"eighty":-1.25629,"marketCap":20871183},{"date":"2025-06-20","current":-2.280483,"twenty":-4.887232,"median":-2.860978,"eighty":-1.26374,"marketCap":19508080},{"date":"2025-06-27","current":-2.036146,"twenty":-4.887232,"median":-2.838342,"eighty":-1.27175,"marketCap":17417929},{"date":"2025-07-03","current":-1.954904,"twenty":-4.887139,"median":-2.830534,"eighty":-1.279614,"marketCap":16722953},{"date":"2025-07-11","current":-2.028001,"twenty":-4.885096,"median":-2.818741,"eighty":-1.282203,"marketCap":17348257},{"date":"2025-07-18","current":-2.341568,"twenty":-4.870867,"median":-2.818639,"eighty":-1.282447,"marketCap":20030618},{"date":"2025-07-25","current":-2.423014,"twenty":-4.840687,"median":-2.812788,"eighty":-1.284531,"marketCap":20727335},{"date":"2025-08-01","current":-2.036146,"twenty":-4.831471,"median":-2.80356,"eighty":-1.289684,"marketCap":17417929},{"date":"2025-08-08","current":-1.834314,"twenty":-4.794301,"median":-2.796461,"eighty":-1.292838,"marketCap":16235251},{"date":"2025-08-15","current":-1.584583,"twenty":-4.783983,"median":-2.773641,"eighty":-1.294523,"marketCap":14024916},{"date":"2025-08-22","current":-1.436594,"twenty":-4.747597,"median":-2.7686,"eighty":-1.297226,"marketCap":12715088},{"date":"2025-08-29","current":-1.806173,"twenty":-4.743873,"median":-2.763695,"eighty":-1.300008,"marketCap":15986175},{"date":"2025-09-05","current":-1.672747,"twenty":-4.728979,"median":-2.733284,"eighty":-1.31051,"marketCap":14805239},{"date":"2025-09-12","current":-1.707185,"twenty":-4.654042,"median":-2.700469,"eighty":-1.312732,"marketCap":15110053},{"date":"2025-09-19","current":-1.553686,"twenty":-4.649853,"median":-2.677999,"eighty":-1.312732,"marketCap":13751454},{"date":"2025-09-26","current":-1.885874,"twenty":-4.607962,"median":-2.65926,"eighty":-1.313449,"marketCap":16691601},{"date":"2025-10-03","current":-1.809321,"twenty":-4.607496,"median":-2.656575,"eighty":-1.313449,"marketCap":16014043},{"date":"2025-10-10","current":-2.951906,"twenty":-4.591671,"median":-2.648612,"eighty":-1.322501,"marketCap":26126893},{"date":"2025-10-17","current":-2.617356,"twenty":-4.591153,"median":-2.639513,"eighty":-1.330438,"marketCap":23165845},{"date":"2025-10-24","current":-2.912547,"twenty":-4.584689,"median":-2.656575,"eighty":-1.332257,"marketCap":25778534},{"date":"2025-10-31","current":-3.010944,"twenty":-4.543874,"median":-2.661944,"eighty":-1.335933,"marketCap":26649431},{"date":"2025-11-07","current":-2.459922,"twenty":-4.519061,"median":-2.668127,"eighty":-1.340207,"marketCap":21772411},{"date":"2025-11-14","current":-2.302486,"twenty":-4.515219,"median":-2.656575,"eighty":-1.342955,"marketCap":20378976},{"date":"2025-11-21","current":-2.109997,"twenty":-4.514872,"median":-2.640081,"eighty":-1.353237,"marketCap":18312473},{"date":"2025-11-28","current":-2.32104,"twenty":-4.497371,"median":-2.637036,"eighty":-1.358688,"marketCap":20144094},{"date":"2025-12-05","current":-2.069594,"twenty":-4.487857,"median":-2.617356,"eighty":-1.360073,"marketCap":17961817},{"date":"2025-12-12","current":-2.127405,"twenty":-4.471975,"median":-2.598599,"eighty":-1.369168,"marketCap":18463554},{"date":"2025-12-19","current":-1.730464,"twenty":-4.467249,"median":-2.593242,"eighty":-1.372225,"marketCap":15018541},{"date":"2025-12-26","current":-1.487399,"twenty":-4.459556,"median":-2.590436,"eighty":-1.373126,"marketCap":12909006},{"date":"2026-01-02","current":-1.199204,"twenty":-4.434402,"median":-2.585905,"eighty":-1.360062,"marketCap":10407781},{"date":"2026-01-09","current":-1.530167,"twenty":-4.377277,"median":-2.560483,"eighty":-1.360062,"marketCap":13280180},{"date":"2026-01-16","current":-1.482886,"twenty":-4.333707,"median":-2.548581,"eighty":-1.364623,"marketCap":12869837},{"date":"2026-01-23","current":-1.35394,"twenty":-4.328319,"median":-2.546651,"eighty":-1.355162,"marketCap":11750721},{"date":"2026-01-30","current":-1.224778,"twenty":-4.323512,"median":-2.534416,"eighty":-1.343819,"marketCap":10629740},{"date":"2026-02-06","current":-1.332449,"twenty":-4.309279,"median":-2.525592,"eighty":-1.333146,"marketCap":11564202},{"date":"2026-02-13","current":-0.958288,"twenty":-4.301253,"median":-2.519557,"eighty":-1.319627,"marketCap":8316899},{"date":"2026-02-20","current":-0.986012,"twenty":-4.284587,"median":-2.505533,"eighty":-1.312732,"marketCap":8557509},{"date":"2026-02-27","current":-1.121836,"twenty":-4.229085,"median":-2.503042,"eighty":-1.297383,"marketCap":9736312},{"date":"2026-03-06","current":-0.937442,"twenty":-4.212284,"median":-2.483493,"eighty":-1.290756,"marketCap":8135975},{"date":"2026-03-13","current":-0.88178,"twenty":-4.16217,"median":-2.479601,"eighty":-1.282203,"marketCap":7652890},{"date":"2026-03-20","current":-0.849329,"twenty":-4.144682,"median":-2.469272,"eighty":-1.266939,"marketCap":7371246},{"date":"2026-03-27","current":-0.852952,"twenty":-4.142046,"median":-2.466441,"eighty":-1.246052,"marketCap":7013129},{"date":"2026-04-02","current":-0.887379,"twenty":-4.119704,"median":-2.459922,"eighty":-1.233855,"marketCap":7296193},{"date":"2026-04-10","current":-0.951211,"twenty":-4.109601,"median":-2.44987,"eighty":-1.223885,"marketCap":7821025},{"date":"2026-04-17","current":-1.16273,"twenty":-4.095468,"median":-2.447548,"eighty":-1.222104,"marketCap":9560174},{"date":"2026-04-24","current":-1.079123,"twenty":-4.088141,"median":-2.442855,"eighty":-1.21045,"marketCap":8872747},{"date":"2026-05-01","current":-0.889382,"twenty":-4.020097,"median":-2.439829,"eighty":-1.190617,"marketCap":7312658},{"date":"2026-05-08","current":-0.861096,"twenty":-3.98728,"median":-2.428063,"eighty":-1.174031,"marketCap":7080086},{"date":"2026-05-15","current":-0.839998,"twenty":-3.971683,"median":-2.423014,"eighty":-1.162324,"marketCap":6997759},{"date":"2026-05-22","current":-0.985763,"twenty":-3.967572,"median":-2.389627,"eighty":-1.154996,"marketCap":8212076},{"date":"2026-05-29","current":-1.442821,"twenty":-3.958471,"median":-2.389627,"eighty":-1.150266,"marketCap":12019681},{"date":"2026-06-05","current":-1.333868,"twenty":-3.942207,"median":-2.386232,"eighty":-1.159943,"marketCap":11112030},{"date":"2026-06-12","current":-1.167351,"twenty":-3.916078,"median":-2.364746,"eighty":-1.150266,"marketCap":9724827},{"date":"2026-06-18","current":-0.970939,"twenty":-3.893403,"median":-2.347049,"eighty":-1.120898,"marketCap":8088586},{"date":"2026-06-26","current":-0.842963,"twenty":-3.866106,"median":-2.335215,"eighty":-1.11123,"marketCap":7022457},{"date":"2026-07-02","current":-0.982567,"twenty":-3.845765,"median":-2.32104,"eighty":-1.093657,"marketCap":8185451},{"date":"2026-07-10","current":-1.168737,"twenty":-3.834772,"median":-2.313795,"eighty":-1.083553,"marketCap":9736379},{"date":"2026-07-17","current":-1.167962,"twenty":-3.815544,"median":-2.302486,"eighty":-1.082544,"marketCap":9729917},{"date":"2026-07-24","current":-1.210109,"twenty":-3.804237,"median":-2.291577,"eighty":-1.083553,"marketCap":10081029},{"date":"2026-07-31","current":-0.88431,"twenty":-3.777432,"median":-2.28257,"eighty":-1.079123,"marketCap":7366906},{"date":"2026-08-07","current":-0.875519,"twenty":-3.759943,"median":-2.278057,"eighty":-1.070472,"marketCap":7293668},{"date":"2026-08-14","current":-0.839689,"twenty":-3.75526,"median":-2.253042,"eighty":-1.060397,"marketCap":7547847},{"date":"2026-08-21","current":-0.810473,"twenty":-3.733802,"median":-2.228095,"eighty":-1.03088,"marketCap":7285234},{"date":"2026-08-28","current":-0.624648,"twenty":-3.73187,"median":-2.211591,"eighty":-1.015379,"marketCap":5614875},{"date":"2026-09-01","current":-0.590815,"twenty":-3.730047,"median":-2.207132,"eighty":-1.011815,"marketCap":5310760}],"updateTime":1788373116769},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NXL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643750605","title":"Nexalin says open-label pilot trial data show 77.8% anxiety response with DIFS brain-stimulation device","url":"https://stock-news.laohu8.com/highlight/detail?id=2643750605","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643750605?lang=en_us&edition=fundamental","pubTime":"2026-06-16 21:15","pubTimestamp":1781615731,"startTime":"0","endTime":"0","summary":"Nexalin flagged two clinical abstracts accepted for the 2026 NYC Neuromodulation Conference; results will be presented at the meeting.Data came from an open-label pilot trial in adults with generalized anxiety disorder and comorbid insomnia using its non-invasive brain-stimulation device.Outcomes showed broad symptom improvement across anxiety, depressive symptoms, insomnia, and quality of life, with benefits described as durable post-treatment.Safety profile appeared favorable, with no serious adverse events reported in the study.Disclosure supports its push toward international commercialization, including a potential Brazil launch, alongside an FDA De Novo pathway strategy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL72zvfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4112","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014039.USD","NDAQ","BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU0314104364.USD","BK4588","IE00BN0W2W23.USD","LU2210149790.SGD","SG9999014005.SGD","BK4082","NXL","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642973421","title":"Nexalin Study Shows Strong Anxiety and Depression Response in Brazil Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642973421","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642973421?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:47","pubTimestamp":1781099225,"startTime":"0","endTime":"0","summary":"Nexalin Technology's  Brazil trial of its Deep Intracranial Frequency Stimulation platform showed a 77.8% response rate for anxiety, along with improvements in depression, insomnia, and overall quality of life, the company said Wednesday.The eight-week, open-label study conducted at the University of Sao Paulo assessed the company's 15 mA, 77.5 Hz neurostimulation protocol in patients with generalized anxiety disorder and co-occurring insomnia, the company said.Nexalin said the trial demonstrated rapid and sustained improvements in anxiety and depression, with benefits lasting through an 8-week follow-up period, and no serious adverse events, seizures, or mood-switching events were reported.The results support the company's planned product launch and commercial expansion in Brazil and further reinforce its non-invasive neurostimulation platform, it added.Shares of the company were up 1.1% in Wednesday trading.Price: 0.46, Change: +0.01, Percent Change: +1.11","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NXL.AU","BK4082","NXL","BK7016","EWZS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642421691","title":"Nexalin Technology completes neurostimulation protocol trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642421691","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642421691?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:32","pubTimestamp":1781098370,"startTime":"0","endTime":"0","summary":"Nexalin Technology (NXL) announced the completion of an 8-week, single-center, prospective, open-label clinical trial evaluating Nexalin’s propriet...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nexalin-technology-completes-neurostimulation-protocol-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nexalin-technology-completes-neurostimulation-protocol-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642429193","title":"Nexalin reports 77.8% anxiety response rate in Brazil trial of DIFS neurostimulation device","url":"https://stock-news.laohu8.com/highlight/detail?id=2642429193","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642429193?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097354,"startTime":"0","endTime":"0","summary":"Nexalin reported results from a completed open-label clinical trial in Brazil testing its non-invasive neurostimulation protocol in adults with anxiety.The study showed broad symptom improvement with benefits that held through follow-up, supporting the case for durable clinical effect.Outcomes also pointed to improvements in related depression and sleep problems, alongside better reported quality of life.Tolerability appeared favorable, with no serious safety issues flagged in the trial readout.The results are being used to support a planned product launch and sales rollout in Brazil.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL45Pjkc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4588","LU2210150020.SGD","NDAQ","IE00BN0W2V16.EUR","NXL","LU0314104364.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","BK4082","BK4112","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642429150","title":"Nexalin Technology - No Serious Adverse Events or Seizures Reported in Nexalin Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642429150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642429150?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097336,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42I0D6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642429131","title":"Nexalin Technology - Reports 77.8% Anxiety Response Rate at End of Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2642429131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642429131?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097336,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42I0D6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642342916","title":"Nexalin Technology - Overall Quality of Life Improves Significantly at End of Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2642342916","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642342916?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097336,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42I0D6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642042913","title":"Nexalin Technology - Completes 8-Week Clinical Trial of 15 Ma, 77.5 Hz Neurostimulation in Anxiety","url":"https://stock-news.laohu8.com/highlight/detail?id=2642042913","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642042913?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097336,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42I0D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640166834","title":"Nexalin Technology Wins US Patent Protecting Neurostimulation Method Through 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2640166834","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640166834?lang=en_us&edition=fundamental","pubTime":"2026-06-04 23:26","pubTimestamp":1780586797,"startTime":"0","endTime":"0","summary":"Nexalin Technology  said the US Patent and Trademark Office issued a patent expected to provide core intellectual property protection for its dynamic frequency stimulation method through 2042, strengthening its competitive position in deep-brain neurostimulation for depression and insomnia.The patent covers methods including transcranial alternating current stimulation, the company said Thursday in a statement.Price: 0.50, Change: -0.03, Percent Change: -5.41","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NXL","BK4082","NXL.AU","BK7016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640163582","title":"Nexalin wins US patent for dynamic frequency brain stimulation targeting anxiety, depression, insomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=2640163582","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640163582?lang=en_us&edition=fundamental","pubTime":"2026-06-04 22:01","pubTimestamp":1780581665,"startTime":"0","endTime":"0","summary":"Nexalin received U.S. Patent No. 12,629,519 covering transcranial alternating current dynamic frequency stimulation methods for anxiety, depression, insomnia.Management expects the patent to provide core U.S. intellectual property protection through 2042.The patent supports the HALO Clarity device platform, Nexalin NeuroCare virtual clinic model, physician-supervised in-home treatment strategy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL4dNCXB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210150020.SGD","NXL","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4585","IE00BN0W2W23.USD","BK4112","BK4588","IE00BGHQF748.EUR","LU0314104364.USD","SG9999014021.USD","SG9999014013.SGD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BKPKM429.USD","NDAQ","SG9999014039.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637336599","title":"Maxim Group Reaffirms Their Buy Rating on Nexalin Technology, Inc. (NXL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637336599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637336599?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:39","pubTimestamp":1779367185,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Anthony Vendetti maintained a Buy rating on Nexalin Technology, Inc. yesterday and set a price target of $2.00. The company’s s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-nexalin-technology-inc-nxl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-nexalin-technology-inc-nxl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636985629","title":"Nexalin closes acquisition of PONM digital health platform for USD 1.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2636985629","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636985629?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:31","pubTimestamp":1779193895,"startTime":"0","endTime":"0","summary":"Nexalin closed the acquisition of PONM from GreenLight Ventures, bringing in-house the digital health platform used for the HALO Clarity program and the Nexalin NeuroCare virtual clinic.Consideration totals $1.3 million, paid in tranches of Nexalin common stock priced to the company’s market performance.The deal includes an exclusive license to software features supporting AI-enabled remote patient monitoring, treatment compliance tracking, EHR functions, and virtual-clinic management.The platform is already deployed at UC San Diego and is being prepared to support a planned 160-participant FDA pivotal trial of HALO Clarity for moderate-to-severe insomnia, with enrollment expected to start in Q2 2026.GreenLight becomes an equity holder in Nexalin and enters a strategic partnership to provide ongoing product, engineering, cybersecurity, regulatory, and commercialization support.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL7pS4pm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IE00BKPKM429.USD","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","NDAQ","IE00B64PRP62.GBP","SG9999014013.SGD","LU2095319765.USD","IE00BN0W2V16.EUR","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014021.USD","LU2210150020.SGD","LU2210149790.SGD","SG9999014039.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4112","BK4585","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636885625","title":"Nexalin Acquires AI-Integrated Digital Health Platform Behind Halo™ Clarity and Nexalin Neurocare™ Ahead of Planned FDA Pivotal Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885625","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636885625?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:30","pubTimestamp":1779193800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA7XRYXH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634469512","title":"Nexalin Q1 FY26 net loss widens 5% to $2.1 million; revenue drops 64% to $14,950","url":"https://stock-news.laohu8.com/highlight/detail?id=2634469512","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634469512?lang=en_us&edition=fundamental","pubTime":"2026-05-09 02:35","pubTimestamp":1778265333,"startTime":"0","endTime":"0","summary":"Nexalin Technology reported a net loss of USD 2.1 million for the three months ended March 31, 2026, widening 5%.Operating loss widened 5% to USD 2.12 million as operating expenses rose 5% to USD 2.13 million.Professional fees climbed 35% to USD 495,296, while salaries and benefits increased 49% to USD 498,560.Entered a Scope of Work with Lindus Health for a pivotal HALO Clarity insomnia clinical trial, with direct fees of about USD 944,820 plus pass-through expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexalin Technology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL7kwtbJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633451408","title":"Nexalin Technology Inc  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633451408","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633451408?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:15","pubTimestamp":1778246108,"startTime":"0","endTime":"0","summary":"Nexalin Technology Inc  expected to post a loss of10cents a share - Earnings Preview Nexalin Technology Inc NXL.OQ NXL.O is expected to  show a fall in quarterly revenue when it reports  results on Ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L1GX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630300814","title":"Nexalin study shows insomnia improvement with 15 mA, 77.5 Hz brain stimulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2630300814","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630300814?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:19","pubTimestamp":1777382359,"startTime":"0","endTime":"0","summary":"Nexalin reported online publication of peer-reviewed results in Psychotherapy and Psychosomatics on April 20, 2026.Findings were already presented via publication, covering a randomized, double-blind, sham-controlled trial in chronic insomnia.Active treatment delivered clear improvement in sleep quality, while sham treatment showed no meaningful change.Neuroimaging results indicated measurable shifts in brain-network activity consistent with a plausible treatment mechanism.Data adds support for Nexalin DIFS platform as company advances HALO Clarity pivotal program toward planned De Novo FDA submission in insomnia.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL8SKw9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4112","IE00BKPKM429.USD","SG9999014021.USD","SG9999014005.SGD","BK4082","NDAQ","NXL","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","LU2095319765.USD","LU0314104364.USD","SG9999014039.USD","BK4585","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630835818","title":"Morgan Stanley Sticks to Their Buy Rating for Nuix Ltd. (NXL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2630835818","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630835818?lang=en_us&edition=fundamental","pubTime":"2026-04-27 09:25","pubTimestamp":1777253112,"startTime":"0","endTime":"0","summary":"In a report released today, Andrew McLeod from Morgan Stanley maintained a Buy rating on Nuix Ltd., with a price target of A$2.50. According to Tip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-nuix-ltd-nxl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-nuix-ltd-nxl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629189188","title":"Nuix Ltd. (NXL) Gets a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2629189188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629189188?lang=en_us&edition=fundamental","pubTime":"2026-04-24 12:06","pubTimestamp":1777003563,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Jackson Lee maintained a Buy rating on Nuix Ltd. on April 22 and set a price target of A$2.30. The word on The Street in genera...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/nuix-ltd-nxl-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/nuix-ltd-nxl-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","LU0029864427.USD","LU0310800379.SGD","LU0128525929.USD","LU0708994859.HKD","LU1267930573.SGD","BK4207","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629023893","title":"BRIEF-Nexalin Technology Advances Clinical Trial Of HALO Clarity Toward Q2 2026 Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2629023893","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629023893?lang=en_us&edition=fundamental","pubTime":"2026-04-22 23:17","pubTimestamp":1776871066,"startTime":"0","endTime":"0","summary":"BRIEF-Nexalin Technology Advances Clinical Trial Of HALO Clarity Toward Q2 2026 EnrollmentApril 22 (Reuters) - Nexalin Technology Inc NXL.O:NEXALIN TECHNOLOGY ADVANCES PIVOTAL CLINICAL TRIAL OF HALO C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629408290","title":"Nexalin Technology enters agreements to advance HALO Clarity trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2629408290","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629408290?lang=en_us&edition=fundamental","pubTime":"2026-04-22 22:03","pubTimestamp":1776866616,"startTime":"0","endTime":"0","summary":"Nexalin Technology (NXL) entered into agreements to advance its planned pivotal clinical trial evaluating the HALO Clarity device for the treatment...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nexalin-technology-enters-agreements-to-advance-halo-clarity-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nexalin-technology-enters-agreements-to-advance-halo-clarity-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL","HALO","LU0053671581.USD","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}